Pain Clinical Trial
— CLINCYTRAMOfficial title:
Observational Study (and Blood Samples Without Genetics Analysis) Tramadol Clinical Efficiency and Tolerance Correlated to O-desmethyltramadol/Tramadol Ratio (CLINCYTRAM)
Verified date | November 2017 |
Source | University Hospital, Caen |
Contact | Anne Sophie Jossome, MD |
Phone | 02 31 06 31 06 |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Tramadol is a grade II analgesics as World Health Organization definition. It can both be an
agonist on mu receptors, which provides it a low opioid action, and also be a
Serotonin-norepinephrine reuptake inhibitor, which act on neuropathic pain.
Tramadol is metabolized by P450 2D6 cytochrome (CYP2D6) in O-desmethyltramadol (O-dt) which
is the most active form on the pharmacologic side (analgesic effect 2 to 4 times more
powerful than tramadol itself).
In caucasian population, 5 to 10% of patients are genetically qualified as "poor metabolizer
phenotype"; this status is correlated to a lower analgesic efficiency compared to "rapid
metabolizer".
A multicenter study, CYTRAM, is under publication and allowed measurement of blood ratio
O-dT/tramadol as a way to know the phenotype of CYP2D6 to detect "poor metabolizer phenotype"
status.
Indeed, blood ratio O-dT/tramadol threshold under 0.1 detects " poor metabolizer phenotype "
status for postoperative patients treated by tramadol, with a good sensibility (87,5%) and
specificity (83.8%).
Which impacts for current practice? The next step is to know if this blood ratio is linked to
an analgesic efficiency and a good tolerance for tramadol. A "poor metabolizer phenotype"
patient would have no benefit of tramadol posology increasing. Therefore, phenotype
detection, thank to blood ratio, could allow to switch quickly tramadol to another analgesic
treatment for "poor metabolizer phenotype" patients.
The main objective of the study is to forge a link between O-dT/tramadol ratio and analgesic
efficiency. Secondary objectives investigate side effects and frequency related to
O-dT/tramadol ratio and pain relief, and also impact of CYP2D6 - inhibitor treatments on the
blood ratio.
If there is a correlation between this blood ratio and treatment efficiency and tolerance,
O-dT/tramadol ratio's detection will allow a better adaptation for some treatments
metabolized by CYP2D6. Therefore, this evolution will contribute to health quality and health
safety improvement.
Status | Recruiting |
Enrollment | 400 |
Est. completion date | November 2018 |
Est. primary completion date | May 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patients >18 years old treated by tramadol for at least 48h - Tramadol posology between 100 and 400 mg/d (oral treatment) and until 600 mg/d (veinous treatment), recommended dosage - Patients with nociceptive pain, definite etiology, combined or not with neuropathic pain - Caucasian patient - Patient able to give his/her informed consent - Patient able to estimate himself/herself pain with pain scale for at least 48h Exclusion Criteria: - Age < 18 years old - Patient with chronic pain (>3 month) or not definite - Tramadol posology >400 mg/d (oral treatment) or > 600 mg/d (veinous treatment) - Patients with absolute Tramadol contraindication - Chronic endstage kidney failure antecedent (Cl cockcroft < 10mL/min) and liver failue antecedent - Concomitant analgesic treatment, except paracetamol or stopped less than 48h ago - Pregnant or breast-feeding patient |
Country | Name | City | State |
---|---|---|---|
France | Caen University Hospital | Caen |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Caen |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Ratio measurement : O-desmethyltramadol blood concentration/ tramadol blood concentration | at 48 hours | ||
Primary | visual analogic pain scale (1 to 10) | at 48 hours |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05559255 -
Changes in Pain, Spasticity, and Quality of Life After Use of Counterstrain Treatment in Individuals With SCI
|
N/A | |
Completed |
NCT04748367 -
Leveraging on Immersive Virtual Reality to Reduce Pain and Anxiety in Children During Immunization in Primary Care
|
N/A | |
Terminated |
NCT04356352 -
Lidocaine, Esmolol, or Placebo to Relieve IV Propofol Pain
|
Phase 2/Phase 3 | |
Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
Completed |
NCT04466111 -
Observational, Post Market Study in Treating Chronic Upper Extremity Limb Pain
|
||
Recruiting |
NCT05868122 -
A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy
|
Phase 3 | |
Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Completed |
NCT03273114 -
Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain
|
N/A | |
Enrolling by invitation |
NCT06087432 -
Is PNF Application Effective on Temporomandibular Dysfunction
|
N/A | |
Completed |
NCT05508594 -
Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001
|
Phase 2/Phase 3 | |
Recruiting |
NCT03646955 -
Partial Breast Versus no Irradiation for Women With Early Breast Cancer
|
N/A | |
Active, not recruiting |
NCT03472300 -
Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
|
||
Completed |
NCT03678168 -
A Comparison Between Conventional Throat Packs and Pharyngeal Placement of Tampons in Rhinology Surgeries
|
N/A | |
Completed |
NCT03931772 -
Online Automated Self-Hypnosis Program
|
N/A | |
Completed |
NCT03286543 -
Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System
|
N/A | |
Completed |
NCT02913027 -
Can We Improve the Comfort of Pelvic Exams?
|
N/A | |
Terminated |
NCT02181387 -
Acetaminophen Use in Labor - Does Use of Acetaminophen Reduce Neuraxial Analgesic Drug Requirement During Labor?
|
Phase 4 | |
Recruiting |
NCT06032559 -
Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
|
Phase 3 | |
Active, not recruiting |
NCT03613155 -
Assessment of Anxiety in Patients Treated by SMUR Toulouse and Receiving MEOPA as Part of Their Care
|